TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06660342: A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

Sponsor: Phathom Pharmaceuticals, Inc. · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 728 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT06660342 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06660342 Rescue Dossier →